Agilent Technologies, Inc. A
172.79
(0.05)
(0.03%)
as of 25 Sep
- Market cap
- $49.0B
- P/E
- 33.9×
Follow A
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years
Agilent Technologies, Inc. (A) Revenue
Agilent Technologies, Inc.'s revenue for fiscal 2025 was $6.9B, up 6.73% from $6.5B in fiscal 2024. Over the twelve months to 31 July 2026 it was $7.4B. Over the past ten years it has ranged from $4.0B (fiscal 2015) to $6.9B (fiscal 2025) — the current reading is the highest in ten years. Agilent Technologies, Inc. ranks 7th of 50 Diagnostics & Research companies by revenue.
Revenue, annual
Annual
| Period | Revenue | Change |
|---|---|---|
| FY2025 | $6.9B | 6.73% |
| FY2024 | $6.5B | (4.73%) |
| FY2023 | $6.8B | (0.22%) |
| FY2022 | $6.8B | 8.37% |
| FY2021 | $6.3B | 18.36% |
| FY2020 | $5.3B | 3.41% |
| FY2019 | $5.2B | 5.07% |
| FY2018 | $4.9B | 9.88% |
| FY2017 | $4.5B | 6.43% |
| FY2016 | $4.2B | 4.06% |
Quarterly
| Period | Revenue | Change |
|---|---|---|
| Jul 2026 | $1.9B | 2.34% |
| Apr 2026 | $1.8B | 2.06% |
| Jan 2026 | $1.8B | (3.39%) |
| Oct 2025 | $1.9B | 7.08% |
| 43 more quarters | Free account |
Against its own ten years
Low $4.0B
High $6.9B
Ten-year median
$5.3B
Current reading's percentile
100
Revenue against peers
| Company | Revenue |
|---|---|
| IQV IQVIA Holdings Inc. compare | $17.0B |
| DGX Quest Diagnostics Incorporated compare | $11.6B |
| A Agilent Technologies, Inc. | $7.4B |
| WAT Waters Corporation compare | $4.6B |
| IDXX IDEXX Laboratories, Inc. compare | $4.6B |
| ILMN Illumina, Inc. compare | $4.5B |
| MTD Mettler-Toledo International, Inc. compare | $4.1B |
| NTRA Natera, Inc. compare | $2.7B |
| GH Guardant Health, Inc. compare | $1.2B |
What Revenue is
Revenue tells an investor how much a company brought in from selling its goods and services over a period, before any costs are taken out.
Reported line item
More on A
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement